Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Amira Mohamed Mohsen, Abeer A. A. Salama & Marwa Hasanein Asfour. (2023) Cubosome-based thermosensitive in situ gelling system for intranasal administration of lamotrigine with enhanced antiepileptic efficacy. Pharmaceutical Development and Technology 28:6, pages 520-534.
Read now
Read now
Tobeka Naki, William Morwa Reagile Matshe, Mohammed Olusegun Balogun, Suprakas Sinha Ray, Samuel Ayodele Egieyeh & Blessing Atim Aderibigbe. (2023) Polymer drug conjugates containing memantine, tacrine and cinnamic acid: promising nanotherapeutics for the treatment of Alzheimer’s disease. Journal of Microencapsulation 40:1, pages 15-28.
Read now
Read now
Ziqi Gu, Haishu Chen, Han Zhao, Wanting Yang, Yilan Song, Xiang Li, Yang Wang, Dan Du, Haikang Liao, Wenhao Pan, Xi Li, Yajuan Gao, Hongbin Han & Zhiqian Tong. (2022) New insight into brain disease therapy: nanomedicines-crossing blood–brain barrier and extracellular space for drug delivery. Expert Opinion on Drug Delivery 19:12, pages 1618-1635.
Read now
Read now
Sema Arisoy, Meryem Kocas, Tansel Comoglu, Ismail Guderer & Sreeparna Banerjee. (2022) Development of ACE2 loaded decoy liposomes and their effect on SARS-CoV-2 for Covid-19 treatment. Pharmaceutical Development and Technology 27:3, pages 290-300.
Read now
Read now
Articles from other publishers (45)
Erwin Pavel Lamparelli, Marianna Marino, Marta Anna Szychlinska, Natalia Della Rocca, Maria Camilla Ciardulli, Pasqualina Scala, Raffaella D'Auria, Antonino Testa, Andrea Viggiano, Francesco Cappello, Rosaria Meccariello, Giovanna Della Porta & Antonietta Santoro. (2023) The Other Side of Plastics: Bioplastic-Based Nanoparticles for Drug Delivery Systems in the Brain. Pharmaceutics 15:11, pages 2549.
Crossref
Crossref
K. Radhakrishnan, P. Senthil Kumar, Gayathri Rangasamy, K. Ankitha, V. Niyathi, V. Manivasagan & K. Saranya. (2023) Recent advances in nanotechnology and its application for neuro-disease: a review. Applied Nanoscience.
Crossref
Crossref
Sara Hernando, Edorta Santos‐Vizcaíno, Manoli Igartua & Rosa Maria Hernandez. (2023) Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease. WIREs Nanomedicine and Nanobiotechnology 15:5.
Crossref
Crossref
Radka Boyuklieva, Plamen Zagorchev & Bissera Pilicheva. (2023) Computational, In Vitro, and In Vivo Models for Nose-to-Brain Drug Delivery Studies. Biomedicines 11:8, pages 2198.
Crossref
Crossref
Emile F. van Vliet, Maarten J. Knol, Raymond M. Schiffelers, Massimiliano Caiazzo & Marcel H.A.M. Fens. (2023) Levodopa-loaded nanoparticles for the treatment of Parkinson's disease. Journal of Controlled Release 360, pages 212-224.
Crossref
Crossref
Thuy Trang Nguyen, Phuong-Trang Nguyen-Thi, Thi Hong Anh Nguyen, Thanh-Tam Ho, Nguyen-Minh-An Tran, Toi Van Vo & Giau Van Vo. (2023) Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders. Molecular Diagnosis & Therapy 27:4, pages 457-473.
Crossref
Crossref
Chiara Puricelli, Casimiro Luca Gigliotti, Ian Stoppa, Sara Sacchetti, Deepika Pantham, Anna Scomparin, Roberta Rolla, Stefania Pizzimenti, Umberto Dianzani, Elena Boggio & Salvatore Sutti. (2023) Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation. Pharmaceutics 15:6, pages 1772.
Crossref
Crossref
Paramita Saha, Himanshu Kathuria & Murali Monohar Pandey. (2023) Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease. Journal of Controlled Release 358, pages 293-318.
Crossref
Crossref
Rebecca Maher, Almudena Moreno-Borrallo, Dhruvi Jindal, Binh T. Mai, Eduardo Ruiz-Hernandez & Andrew Harkin. (2023) Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery. Pharmaceutics 15:3, pages 746.
Crossref
Crossref
Anja Haasbroek‐Pheiffer, Suzanne Van Niekerk, Frank Van der Kooy, Theunis Cloete, Jan Steenekamp & Josias Hamman. (2023)
In vitro
and
ex vivo
experimental models for evaluation of intranasal systemic drug delivery as well as direct nose‐to‐brain drug delivery
. Biopharmaceutics & Drug Disposition 44:1, pages 94-112.
Crossref
Crossref
Li Du, Lin Chen, Fangfang Liu, Wenya Wang & Hongyun Huang. 2023. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors
255
297
.
Deepshi Arora, Shailendra Bhatt, Manish Kumar, Rupesh K. Gautam, Yugam Taneja & Muskan Chauhan. 2023. Recent Advances in Pharmaceutical Innovation and Research. Recent Advances in Pharmaceutical Innovation and Research
447
477
.
Thi Hong Nhung Vu, Svetlana Morozkina, Petr Snetkov & Mayya Uspenskaya. 2023. Nano- and Microfabrication Techniques in Drug Delivery. Nano- and Microfabrication Techniques in Drug Delivery
429
466
.
Obaydah Abd Alkader Alabrahim & Hassan Mohamed El-Said Azzazy. (2022) Polymeric nanoparticles for dopamine and levodopa replacement in Parkinson's disease. Nanoscale Advances 4:24, pages 5233-5244.
Crossref
Crossref
Ahmed Hafez Mousa & Salwa Agha Mohammad. (2022) Potential role of chitosan, PLGA and iron oxide nanoparticles in Parkinson’s disease therapy. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 58:1.
Crossref
Crossref
Guowang Cheng, Yujing Liu, Rui Ma, Guopan Cheng, Yucheng Guan, Xiaojia Chen, Zhenfeng Wu & Tongkai Chen. (2022) Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials. Nano-Micro Letters 14:1.
Crossref
Crossref
Margarita E. Neganova, Yulia R. Aleksandrova, Olga A. Sukocheva & Sergey G. Klochkov. (2022) Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Seminars in Cancer Biology 86, pages 805-833.
Crossref
Crossref
A.C. Correia, A.R. Monteiro, R. Silva, J.N. Moreira, J.M. Sousa Lobo & A.C. Silva. (2022) Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood–brain barrier (BBB) to manage neurological disorders. Advanced Drug Delivery Reviews 189, pages 114485.
Crossref
Crossref
Pratikshya Sa, Priya Singh, Fahima Dilnawaz & Sanjeeb Kumar Sahoo. (2022) Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment
of CNS Disorders: Challenges and Possibilities. Current Pharmaceutical Design 28:33, pages 2742-2757.
Crossref
Crossref
Miguel Pinto, Vera Silva, Sandra Barreiro, Renata Silva, Fernando Remião, Fernanda Borges & Carlos Fernandes. (2022) Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform. Ageing Research Reviews 79, pages 101658.
Crossref
Crossref
Aijie Chen, Yiyuan Kang, Jia Liu, Junrong Wu, Xiaoli Feng, Menglei Wang, Yanli Zhang, Ruolan Wang, Xuan Lai & Longquan Shao. (2022) Improvement of synaptic plasticity by nanoparticles and the related mechanisms: Applications and prospects. Journal of Controlled Release 347, pages 143-163.
Crossref
Crossref
Xuan Liu, Shen Yan, Mengyuan Li, Shengyu Zhang, Gang Guo, Quanyi Yin, Zhenbo Tong, Xiao Dong Chen & Winston Duo Wu. (2022) Spray Dried Levodopa-Doped Powder Potentially for Intranasal Delivery. Pharmaceutics 14:7, pages 1384.
Crossref
Crossref
Yaquelyn Casanova, Sofía Negro, Karla Slowing, Luis García-García, Ana Fernández-Carballido, Mahdieh Rahmani & Emilia Barcia. (2022) Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease. Pharmaceutics 14:5, pages 1080.
Crossref
Crossref
Gaetano Barbato, Robert Nisticò & Viviana Triaca. (2022) Exploiting Focused Ultrasound to Aid Intranasal Drug Delivery for Brain Therapy. Frontiers in Pharmacology 13.
Crossref
Crossref
Savvas Dimiou, Rui M. Lopes, Ilona Kubajewska, Ryan D. Mellor, Corinna S. Schlosser, Manjunath S. Shet, Hugh Huang, Ozgur Akcan, Garth T. Whiteside, Andreas G. Schätzlein & Ijeoma F. Uchegbu. (2022) Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure. International Journal of Pharmaceutics 618, pages 121658.
Crossref
Crossref
Mohd Zulhelmy Ahmad, Akmal Hidyat Bin Sabri, Qonita Kurnia Anjani, Juan Domínguez-Robles, Normala Abdul Latip & Khuriah Abdul Hamid. (2022) Design and Development of Levodopa Loaded Polymeric Nanoparticles for Intranasal Delivery. Pharmaceuticals 15:3, pages 370.
Crossref
Crossref
Sema Arisoy & Tansel Comoglu. (2022) Effect of Formulation Variables for the Production of WGA-Grafted, Levodopa-Loaded PLGA Nanoparticles. Journal of Biomimetics, Biomaterials and Biomedical Engineering 54, pages 1-15.
Crossref
Crossref
Honey Goel, Vinni Kalra, Sant Kumar Verma, Sunil Kumar Dubey & Ashok Kumar Tiwary. (2022) Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies. Journal of Controlled Release 341, pages 782-811.
Crossref
Crossref
Javed Ahmad, Nafis Haider, Mohammad Ahmed Khan, Shadab Md, Nabil A. Alhakamy, Mohammed M. Ghoneim, Sultan Alshehri, Syed Sarim Imam, Mohammad Zaki Ahmad & Awanish Mishra. (2022) Novel therapeutic interventions for combating Parkinson’s disease and prospects of Nose-to-Brain drug delivery. Biochemical Pharmacology 195, pages 114849.
Crossref
Crossref
Harsha Jain, Harshita Dalvi, Aditi Bhat, Aashruti Agrawal, Jitender Madan, Pankaj Kumar Singh, Neelesh Kumar Mehra, Shashi Bala Singh & Saurabh Srivastava. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers
379
400
.
Rupinder Kaur Sodhi, Jitender Madan, M. Arockia Babu & Yuvraj Singh. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers
419
439
.
Claudia Riccardi, Filomena Napolitano, Daniela Montesarchio, Simone Sampaolo & Mariarosa Anna Beatrice Melone. (2021) Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases. Pharmaceutics 13:11, pages 1897.
Crossref
Crossref
Ajit Singh, Sandeep Kumar Maharana, Rahul Shukla & Prashant Kesharwani. (2021) Nanotherapeutics approaches for targeting alpha synuclien protein in the management of Parkinson disease. Process Biochemistry 110, pages 181-194.
Crossref
Crossref
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tuong Kha Vo, Nguyen-Minh-An Tran, Minh Kim Nguyen, Toi Van Vo & Giau Van Vo. (2021) Nanotechnology-based drug delivery for central nervous system disorders. Biomedicine & Pharmacotherapy 143, pages 112117.
Crossref
Crossref
Laura Deruyver, Clément Rigaut, Pierre Lambert, Benoît Haut & Jonathan Goole. (2021) The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery. Advanced Drug Delivery Reviews 175, pages 113826.
Crossref
Crossref
Anthony Cunha, Alexandra Gaubert, Laurent Latxague & Benjamin Dehay. (2021) PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases. Pharmaceutics 13:7, pages 1042.
Crossref
Crossref
Ajay Vikram Singh, Vaisali Chandrasekar, Poonam Janapareddy, Divya Elsa Mathews, Peter Laux, Andreas Luch, Yin Yang, Beatriz Garcia-Canibano, Shidin Balakrishnan, Julien Abinahed, Abdulla Al Ansari & Sarada Prasad Dakua. (2021) Emerging Application of Nanorobotics and Artificial Intelligence To Cross the BBB: Advances in Design, Controlled Maneuvering, and Targeting of the Barriers. ACS Chemical Neuroscience 12:11, pages 1835-1853.
Crossref
Crossref
Natália N. Ferreira, Edilson de Oliveira Junior, Sara Granja, Fernanda I. Boni, Leonardo M.B. Ferreira, Beatriz S.F. Cury, Lilian C.R. Santos, Rui M. Reis, Eliana M. Lima, Fátima Baltazar & Maria Palmira D. Gremião. (2021) Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system. International Journal of Pharmaceutics 603, pages 120714.
Crossref
Crossref
Jonathan Baskin, June Evelyn Jeon & Simon J. G. Lewis. (2020) Nanoparticles for drug delivery in Parkinson’s disease. Journal of Neurology 268:5, pages 1981-1994.
Crossref
Crossref
Sara Silva, António Almeida & Nuno Vale. (2021) Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs. Pharmaceutics 13:4, pages 508.
Crossref
Crossref
Ikram Ahmad, Hina Tabassum, Farwa Batool Shamsi, Saad Maroof Saeed, Awais Ahmad & Shahid Hussain. 2021. Nanomedicine Manufacturing and Applications. Nanomedicine Manufacturing and Applications
173
191
.
Natália N. Ferreira, Sara Granja, Fernanda I. Boni, Fabíola G. Prezotti, Leonardo M. B. Ferreira, Beatriz S. F. Cury, Rui M. Reis, Fátima Baltazar & Maria Palmira D. Gremião. (2020) Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route. Drug Delivery and Translational Research 10:6, pages 1729-1747.
Crossref
Crossref
Rugmani Meenambal & M.M. Srinivas Bharath. (2020) Nanocarriers for effective nutraceutical delivery to the brain. Neurochemistry International 140, pages 104851.
Crossref
Crossref
Tao Ming Sim, Dinesh Tarini, S. Thameem Dheen, Boon Huat Bay & Dinesh Kumar Srinivasan. (2020) Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders. International Journal of Molecular Sciences 21:17, pages 6070.
Crossref
Crossref
Ankita Paul & Khushwant S. Yadav. (2020) Parkinson's disease: Current drug therapy and unraveling the prospects of nanoparticles. Journal of Drug Delivery Science and Technology 58, pages 101790.
Crossref
Crossref